STAT3 and neoplasm: That is very interesting since STAT3 activation sustains tumour growth properties, including the support of stemness, in diverse cancer types including those of the breast, prostate, and brain and targeting STAT3 or its crucial upstream activators could result in the disruption of GSC maintenance and this pathway could represent a potential therapeutic target [80,82,83,84,85,86,87].